Roche plans new vitamin plant in Switzerland

The Roche healthcare group in Basel said on Friday it plans to invest some SFr170 million ($95 million) to build a new manufacturing plant for vitamin E in Sisseln, canton Aargau.

This content was published on October 20, 2000 - 11:49

In a statement, Roche said the new facility, with an annual production capacity of 25,000 tonnes, would incorporate the latest technologies and production processes.

It added that the project was part of a global plan aimed at upgrading production facilities to the latest technological standards and ensuring that manufacturing operations were located as strategically as possible.

In the medium term, the Sisseln plant will replace existing plants at Nutley (New Jersey) and Sisseln itself.

Sisseln is one of Roche's most important production sites in the Vitamins and Fine Chemicals Division.

Vitamin E plays a major role in protecting body tissues from harmful reactions that can be caused by normal metabolic processes or environmental toxins. The vitamin has a wide range of uses in the food and pharmaceutical industries, and in modern animal production.

swissinfo with agencies

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.